Advertisement

Ads Placeholder
Loading...

Healthcare Capital Corp.

HCCCWNASDAQ
Financial Services
Shell Companies
$0.49
$0.07(16.67%)
U.S. Market is Open • 11:49

Healthcare Capital Corp. Fundamental Analysis

Healthcare Capital Corp. (HCCCW) shows weak financial fundamentals with a PE ratio of -33.76, profit margin of 0.00%, and ROE of -67.45%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.34

Areas of Concern

ROE-67.45%
Operating Margin0.00%
Current Ratio0.13
We analyze HCCCW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -8405.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-8405.7/100

We analyze HCCCW's fundamental strength across five key dimensions:

Efficiency Score

Weak

HCCCW struggles to generate sufficient returns from assets.

ROA > 10%
-60.93%

Valuation Score

Excellent

HCCCW trades at attractive valuation levels.

PE < 25
-33.76
PEG Ratio < 2
-0.34

Growth Score

Weak

HCCCW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

HCCCW shows balanced financial health with some risks.

Debt/Equity < 1
0.00
Current Ratio > 1
0.13

Profitability Score

Weak

HCCCW struggles to sustain strong margins.

ROE > 15%
-6745.14%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is HCCCW Expensive or Cheap?

P/E Ratio

HCCCW trades at -33.76 times earnings. This suggests potential undervaluation.

-33.76

PEG Ratio

When adjusting for growth, HCCCW's PEG of -0.34 indicates potential undervaluation.

-0.34

Price to Book

The market values Healthcare Capital Corp. at -1261.55 times its book value. This may indicate undervaluation.

-1261.55

EV/EBITDA

Enterprise value stands at -0.00 times EBITDA. This is generally considered low.

-0.00

How Well Does HCCCW Make Money?

Net Profit Margin

For every $100 in sales, Healthcare Capital Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-67.45 in profit for every $100 of shareholder equity.

-67.45%

ROA

Healthcare Capital Corp. generates $-60.93 in profit for every $100 in assets, demonstrating efficient asset deployment.

-60.93%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-33.76

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.34

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1261.55

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.13

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-67.45

vs 25 benchmark

ROA

Return on assets percentage

-60.93

vs 25 benchmark

ROCE

Return on capital employed

34.87

vs 25 benchmark

How HCCCW Stacks Against Its Sector Peers

MetricHCCCW ValueSector AveragePerformance
P/E Ratio-33.7618.59 Better (Cheaper)
ROE-6745.14%801.00% Weak
Net Margin0.00%-498.00% (disorted) Weak
Debt/Equity0.000.98 Strong (Low Leverage)
Current Ratio0.13661.40 Weak Liquidity
ROA-6093.49%-21324.00% (disorted) Weak

HCCCW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Healthcare Capital Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

Fundamental Analysis FAQ